NO20074228L - Nye farmasoytiske blandinger som er nyttige ved smertelindring - Google Patents

Nye farmasoytiske blandinger som er nyttige ved smertelindring

Info

Publication number
NO20074228L
NO20074228L NO20074228A NO20074228A NO20074228L NO 20074228 L NO20074228 L NO 20074228L NO 20074228 A NO20074228 A NO 20074228A NO 20074228 A NO20074228 A NO 20074228A NO 20074228 L NO20074228 L NO 20074228L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
carrier particles
particles
pain relief
compositions useful
Prior art date
Application number
NO20074228A
Other languages
English (en)
Norwegian (no)
Inventor
Anders Pettersson
Thomas Lundqvist
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of NO20074228L publication Critical patent/NO20074228L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20074228A 2005-03-28 2007-08-20 Nye farmasoytiske blandinger som er nyttige ved smertelindring NO20074228L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66537705P 2005-03-28 2005-03-28
PCT/GB2006/001133 WO2006103418A1 (en) 2005-03-28 2006-03-28 New pharmaceutical compositions useful in the treatment of pain

Publications (1)

Publication Number Publication Date
NO20074228L true NO20074228L (no) 2007-11-28

Family

ID=34956745

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074228A NO20074228L (no) 2005-03-28 2007-08-20 Nye farmasoytiske blandinger som er nyttige ved smertelindring

Country Status (11)

Country Link
US (1) US20080248110A1 (enExample)
EP (1) EP1863456A1 (enExample)
JP (1) JP2008534564A (enExample)
KR (1) KR20080002788A (enExample)
CN (1) CN101151021A (enExample)
CA (1) CA2599386A1 (enExample)
IL (1) IL185462A0 (enExample)
MX (1) MX2007011977A (enExample)
NO (1) NO20074228L (enExample)
RU (1) RU2007139827A (enExample)
WO (1) WO2006103418A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
ATE495732T1 (de) 2003-03-26 2011-02-15 Egalet As Morphin-system mit kontrollierter freisetzung
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
PL2101740T3 (pl) 2006-12-04 2014-04-30 Orexo Ab Nowa, niepodatna na nadużycie kompozycja farmaceutyczna zawierająca opioidy
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
EP3090743A1 (en) * 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
AU2011305161A1 (en) * 2010-09-24 2013-05-09 QRxPharma Ltd. Controlled release formulations of opioids
CA2816420C (en) * 2010-10-29 2018-01-16 Najib Babul Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol
PL2706986T3 (pl) 2011-09-19 2015-08-31 Orexo Ab Nowa niepodatna na nadużywanie kompozycja farmaceutyczna do leczenia uzależnienia od opioidów
CN103224572A (zh) * 2012-01-31 2013-07-31 岳旺 褐藻酸铈配合物的制备及作为抗呕吐药物的用途
CN102614162B (zh) * 2012-02-17 2014-04-02 武汉康丽源医药科技有限公司 姜辣素与草酸铈组合物在制备癌症化疗中减毒增效药物中的用途
SI2849730T1 (sl) 2012-05-02 2017-02-28 Orexo Ab Novi sestavek alfentanila za zdravljenje akutne bolečine
HK1210599A1 (en) 2012-07-06 2016-04-29 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CN103705493B (zh) * 2013-12-24 2014-11-12 山西皇城相府药业有限公司 一种氢溴酸右美沙芬口腔分散膜剂及其制备方法
ES2809458T3 (es) 2014-07-17 2021-03-04 Pharmaceutical Manufacturing Res Services Inc Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2016161537A1 (en) * 2015-04-08 2016-10-13 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granistron
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
EP3727384A4 (en) 2017-12-20 2021-11-03 Purdue Pharma L.P. ABUSE-DISSUASIVE MORPHINE SULPHATE FORMES
WO2019155389A1 (en) * 2018-02-06 2019-08-15 Target Oncology Inc. An aqueous mucoadhesive and bioadhesive composition for the treatment
CN111170886B (zh) * 2020-01-03 2021-11-09 扬子江药业集团有限公司 一种地佐辛杂质的制备方法
US11247999B1 (en) 2021-07-02 2022-02-15 Joseph DeGraw Facile conversion of morphine to normorphine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6376550B1 (en) * 1999-02-09 2002-04-23 Asta Medica Ag Pharmaceutical compositions containing tramadol for migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
SI1587514T1 (sl) * 2003-01-31 2006-10-31 Orexo Ab Hitro ucinkujoc farmacevtski sestavek

Also Published As

Publication number Publication date
MX2007011977A (es) 2007-12-07
WO2006103418A1 (en) 2006-10-05
KR20080002788A (ko) 2008-01-04
IL185462A0 (en) 2008-01-06
CA2599386A1 (en) 2006-10-05
EP1863456A1 (en) 2007-12-12
RU2007139827A (ru) 2009-05-10
JP2008534564A (ja) 2008-08-28
CN101151021A (zh) 2008-03-26
US20080248110A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
NO20074228L (no) Nye farmasoytiske blandinger som er nyttige ved smertelindring
AU2003263599A1 (en) Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
PT1587514E (pt) Composicao farmaceutica de accao rapida
MXPA06010900A (es) Inhibidores de histona desacetilasa.
WO2003080070A3 (en) Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
MY144477A (en) Galenic formulations of organic compounds
WO2007072503A3 (en) Combinations for managing inflammation and associated disorders
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
SI2489659T1 (en) Modulators of ATP-binding cassette transporters
PT1487461E (pt) Métodos de utilização e composições compreendendo compostos imunomoduladores para o tratamento e gestão de síndromes mielodisplásicas
PL1697370T3 (pl) Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2003247083A1 (en) Process for making orally consumable dosage forms
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2004041188A3 (en) Compositions and methods for transdermal oxybutynin therapy
EP1508570A4 (en) NEW PHYSIOLOGICAL ACTIVE SUBSTANCES
WO2006103407A3 (en) New pharmaceutical compositions useful in the treatment of migraine
WO2008057780A3 (en) Transdermal delivery of ketoprofen polar derivatives
AU4884696A (en) Pharmaceutical compositions comprising monoamine oxidase B inhibitors
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
WO2005117895A8 (en) Compositions comprising meloxicam
WO2005004915A3 (en) Compositions comprising meloxicam
IL178122A0 (en) Materials and methods for treating coagulation disorders
WO2003063840A3 (en) Transmucosal delivery of proton pump inhibitors
WO2005123192A3 (en) Improving pain treatment with strontium combinations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application